Publications
Below is a list of research publications published in scientific journals by IDDO and WWARN and our research partners. Use the filters to explore the publications by research theme or by using our list of key words. If you cannot find a publication, please email info@iddo.org
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions.
Schilling, W., Callery, J., Chandna, A., Hamers, R., Watson, J., & White, N. (2021). Wellcome Open Research, 6, 71.
Questioning the claimed superiority of malaria parasite ex vivo viability reduction over observed parasite clearance rate?
White, N., & Watson, J. (2020). The Journal of Infectious Diseases, 224(4), 738-739.
Is malaria parasite ex-vivo viability reduction really "superior" to observed parasite clearance rate?
White, N., & Watson, J. (2020). The Journal of Infectious Diseases.
Outcome of Japanese Encephalitis Virus (JEV) infection in pediatric and adult patients at Mahosot Hospital, Vientiane, Lao PDR
Mayxay, M., Douangdala, P., Vilayhong, C., Phommasone, K., Chansamouth, V., Vongsouvath, M., Rattanavong, S., Chang, K., Sengvilaipaseuth, O., Chanthongthip, A., Thongpaseuth, S., Newton, P., & Dubot-Pérès, A. (2020). American Journal of Tropical Medicine and Hygiene, 104(2), 567-575.
A systematic literature review of microscopy methods reported in malaria clinical trials
Das, D., Dahal, P., Dhorda, M., Citarella, B., Kennon, K., Stepniewska, K., Felger, I., Chappuis, F., & Guerin, P. (2020). American Journal of Tropical Medicine and Hygiene, 104(3), 836-841.
Comparison of Rapid Antigen Tests for COVID-19
Yamayoshi, S., Sakai-Tagawa, Y., Koga, M., Akasaka, O., Nakachi, I., Koh, H., Maeda, K., Adachi, E., Saito, M., Nagai, H., Ikeuchi, K., Ogura, T., Baba, R., Fujita, K., Fukui, T., Ito, F., Hattori, S.-I., Yamamoto, K., Nakamoto, T., … Kawaoka, Y. (2020). Viruses, 12(12), 1420.
Diagnostic accuracy of an in-house Scrub Typhus enzyme linked immunoassay for the detection of IgM and IgG antibodies in Laos.
Elders, P., Dhawan, S., Tanganuchitcharnchai, A., Phommasone, K., Chansamouth, V., Day, N., Garcia-Rivera, J., Hertz, J., Mayxay, M., Vongsouvath, M., Dubot-Pérès, A., Robinson, M., Newton, P., & Blacksell, S. (2020). PLoS Neglected Tropical Diseases, 14(12).
Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership—Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis
Hauk, C., Schäfermann, S., Martus, P., Muzafarova, N., Babaley, M., Waning, B., & Heide, L. (2020). PLOS ONE, 15(12), e0243428.
Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial
Chowdhury, F., Hoque, A., Chowdhury, F., Amin, M., Rahim, A., Rahman, M., Yasmin, R., Amin, M., Miah, M., Kalam, M., & Rahman, M. (2020). Trials, 21(1), 883.
Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error
Watson, J., & Holmes, C. (2020). Trials, 21(1), 156.
Impact of delays to incubation and storage temperature on blood culture results in tropical countries: A multi-centre study
Soeng, S., Ling, C., Cusack, T.-P., Dance, D., Hinfonthong, P., Lee, S., Newton, P., Nosten, F., Reed, T., Roberts, T., Sengduangphachanh, A., Sihalath, S., Wangrangsimakul, T., Turner, P., & Ashley, E. (2020). INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101(Supplement 1), 195-195.
Graphing and reporting heterogeneous treatment effects through reference classes
Watson, J., & Holmes, C. (2020). Trials, 21(1), 386.
Hepcidin-mediated hypoferremia disrupts immune responses to vaccination and infection
Frost, J., Tan, T., Abbas, M., Wideman, S., Bonadonna, M., Stoffel, N., Wray, K., Kronsteiner-Dobramysl, B., Smits, G., Campagna, D., Duarte, T., Lopes, J., Shah, A., Armitage, A., Arezes, J., Lim, P., Preston, A., Ahern, D., Teh, M., … Drakesmith, H. (2020). Med, 2(2), 164 - 179.e12.
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
Hossain, M., Commons, R., Douglas, N., Thriemer, K., Alemayehu, B., Amaratunga, C., Anvikar, A., Ashley, E., Asih, P., Carrara, V., Lon, C., D’Alessandro, U., Davis, T., Dondorp, A., Edstein, M., Fairhurst, R., Ferreira, M., Hwang, J., Janssens, B., … Price, R. (2020). PLOS Medicine, 17(11).
A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell's viper antivenom in Myanmar
Watson, J., Lamb, T., Holmes, J., Warrell, D., Thwin, K., Aung, Z., Oo, M., Nwe, M., Smithuis, F., & Ashley, E. (2020). PLoS Neglected Tropical Diseases, 14(11).
Time-dependent microglia and macrophages response after traumatic spinal cord injury in rat: a systematic review
Rezvan, M., Meknatkhah, S., Hassannejad, Z., Sharif-Alhoseini, M., Zadegan, S., Shokraneh, F., Vaccaro, A., Lu, Y., & Rahimi-Movaghar, V. (2020). Injury, 51(11), 2390-2401.
Assessing the quality of meta-analyses in systematic reviews in pharmaceutical research in Iran by 2016: A systematic review
Amanollahi, A., Moradi-Lakeh, M., Shokraneh, F., Bashiri, Y., & Mahmudi, L. (2020). Medical Journal of the Islamic Republic of Iran, 34(1), 209-216.
How many human pathogens are there in Laos? An estimate of national human pathogen diversity and analysis of historical trends.
Clarkson, M., Aguas, R., Sweet, K., Roberts, T., Strobel, M., & Newton, P. (2020). BMJ Global Health, 5(10).
Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019
Rathmes, G., Rumisha, S., Lucas, T., Twohig, K., Python, A., Nguyen, M., Nandi, A., Keddie, S., Collins, E., Rozier, J., Gibson, H., Chestnutt, E., Battle, K., Humphreys, G., Amratia, P., Arambepola, R., Bertozzi-Villa, A., Hancock, P., Millar, J., … Weiss, D. (2020). Malaria Journal, 19(1).
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
Schilling, W., Callery, J., Taylor, W., Mukaka, M., Ekkapongpisit, M., Watson, J., Chandna, A., Panapipat, S., Tubprasert, J., Yuentrakul, P., Waithira, N., Cope, T., Dhorda, M., Cruz, C., von Seidlein, L., Milton, J., LLewelyn, M., Adler, A., Chotivanich, K., … White, N. (2020). Wellcome Open Research, 5, 241-241.
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
Nebot Giralt, A., Bourasseau, A., White, G., Pouget, C., Tabernero, P., Van Assche, K., & Ravinetto, R. (2020). BMJ Global Health, 5(10).
A cautionary note on the use of unsupervised machine learning algorithms to characterise malaria parasite population structure from genetic distance matrices
Watson, J., Taylor, A., Ashley, E., Dondorp, A., Buckee, C., White, N., & Holmes, C. (2020). PLoS Genetics, 16(10).
Effect of hydroxychloroquine in hospitalized patients with COVID-19
Horby, P., Mafham, M., Linsell, L., Bell, J., Staplin, N., Emberson, J., Tarning, J., Watson, J., White, N., Juszczak, E., Haynes, R., & Landray, M. (2020). New England Journal of Medicine, 383(21), 2030-2040.
Early General Hypothermia Improves Motor Function after Spinal Cord Injury in Rats; a Systematic Review and Meta-Analysis.
Yousefifard, M., Vazirizadeh-Mahabadi, M., Haghani, L., Shokraneh, F., Vaccaro, A., Rahimi-Movaghar, V., & Hosseini, M. (2020). Archives of Academic Emergency Medicine, 8(1), e80.
Correction to: Graphing and reporting heterogeneous treatment effects through reference classes.
Watson, J., & Holmes, C. (2020). Trials, 21(1), 865.